Single Inhibitors versus Dual Inhibitors: Role of HDAC in Cancer-Reference-Cited by-同舟云学术

Single Inhibitors versus Dual Inhibitors: Role of HDAC in Cancer

Published:2023-05-01 Issue:19 Volume:8 Page:16532-16544
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Roy Rubi¹,Ria Tasnim¹,RoyMahaPatra Debapriya¹,Sk Ugir Hossain¹^ORCID

Affiliation:

1. Department of Clinical and Translational Research, Chittaranjan National Cancer Institute, 37 S.P. Mukherjee Road, Kolkata, West Bengal 700026, India

Funder

Council of Scientific and Industrial Research, India

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.3c00222

Reference77 articles.

1. Quinazoline Based HDAC Dual Inhibitors as Potential Anti-Cancer Agents

2. Targeted Cancer Therapy: The Next Generation of Cancer Treatment

3. The role of tamoxifen in the treatment and prevention of breast cancer

4. Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective

5. Combination therapy in combating cancer

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FLT3-PROTACs for combating AML resistance: Analytical overview on chimeric agents developed, challenges, and future perspectives;European Journal of Medicinal Chemistry;2024-11

2. Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesterase;Journal of Molecular Liquids;2024-09

3. Discovery of a dual-target DYRK2 and HDAC8 inhibitor for the treatment of hepatocellular carcinoma;Biomedicine & Pharmacotherapy;2024-08

4. Kuwanon C Inhibits Tumor Cell Proliferation and Induces Apoptosis by Targeting Mitochondria and Endoplasmic Reticulum;International Journal of Molecular Sciences;2024-07-30

5. Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growth;PLOS ONE;2024-07-15